Annual report pursuant to Section 13 and 15(d)

NOTE 4 - MERGER WITH CLS LABS

v3.2.0.727
NOTE 4 - MERGER WITH CLS LABS
 12 Months Ended
May. 31, 2015
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]
NOTE 4 - MERGER WITH CLS LABS

On April 29, 2015, the Company, CLS Labs and CLS Merger, Inc., a Nevada corporation and wholly owned subsidiary of the Company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger, Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). Upon the consummation of the Merger, the shares of the common stock of CLS Holdings owned by CLS Labs were extinguished and the stockholders of CLS Labs were issued an aggregate of 15,000,000 (post Reverse Split) shares of common stock in the Company in exchange for their shares of common stock in CLS Labs. As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business.

Pro Forma Results

The following tables set forth the unaudited pro forma results of the Company as if the acquisition of CLS Labs had taken place on the first day of the periods presented. These combined results are not necessarily indicative of the results that may have been achieved had the companies always been combined.

   
Twelve months ended
 
   
May 31, 2015
 
Total Revenue
   
-
 
Net loss attributable to CLS Holdings USA, Inc.
   
(2,200,788
) 
Basic net income (loss) per common share
   
(0.35
)
Diluted net income (loss) per common share
   
(0.35
) 
Weighted average shares - basic
   
6,356,167
 
Weighted average shares - diluted
   
6,356,167